Myriad Genetics Inc (MYGN) Reports 11% Revenue Growth in Q4 and Full-Year 2023
Company Raises 2024 Revenue Guidance and Delivers Positive Adjusted EPS in Q4
Source: yahoo.com
Stay updated with breaking news from Diagnostics Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Company Raises 2024 Revenue Guidance and Delivers Positive Adjusted EPS in Q4
Financial Highlights and Business Developments
GH Anticipates Continued Expansion with 2024 Revenue Outlook Set Between $655 to $670 Million
Exact Sciences Corp (EXAS) Announces 17% Revenue Increase and Provides Optimistic 2024 Outlook
NEO Sees 12% Quarterly Revenue Increase and 37% Decrease in Net Loss